From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c03145
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03145
其他信息:
出版社: American Chemical Society (ACS)
作者: Jihong Wan; Xiao-Yu Xiong; Zixiang Geng; Benjun Yuan; Youzhen Ma; Yan Zhao; Zhi Ying Dorothy Wong; Xinyi Kang; Rui Fan; Delin Min; Huanren Yan; Yibo Chen; Dong-Yi He; Jian-Ping Zuo; Han-Chen Xu; Yang Ding; Zhiyi Liu; Zixin Hu; Fuzhuo Li; Nannan Sun; Yongfang Zhao; Ze-Min Lin; Mei-Lin Tang
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03145
